Potent inhibition of tau fibrillization with a multivalent ligand

Biochemical and Biophysical Research Communications

Volumn 363, Issue 1, 2007, Pages 229-234

  Honson, Nicolette S ^a   Jensen, Jordan R ^a   Darby, Michael V ^b   Kuret, Jeff ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Aggregation; Alzheimer's disease; Cyanine dye; Neurofibrillary tangle; Tau

Indexed keywords

CARBOCYANINE; CYANINE DYE; LIGAND; PROTEIN INHIBITOR; TAU PROTEIN;

ABSORPTION SPECTROSCOPY; AQUEOUS SOLUTION; ARTICLE; CONCENTRATION (PARAMETERS); DRUG POTENCY; DRUG SYNTHESIS; ELECTRON MICROSCOPY; PRIORITY JOURNAL; PROTEIN AGGREGATION; QUANTITATIVE ANALYSIS;

AMYLOID; BINDING SITES; CARBOCYANINES; LIGANDS; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; TAU PROTEINS;

EID: 34548723284     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.08.166     Document Type: Article

References (27)

1. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., and Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33 (2000) 95-130
2. Caughey B., and Lansbury P.T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26 (2003) 267-298
3. Kuret J. Detection and Reduction of Neurofibrillary Lesions. In: Smith H.J., Sewell R.D.E., and Simons C. (Eds). Protein Folding Diseases: Enzyme Inhibitors and Other Agents as Prospective Therapies (2007), CRC Press/Taylor & Francis Books, Boca Raton, FL 287-324
4. Kuret J., Congdon E.E., Li G., Yin H., Yu X., and Zhong Q. Evaluating triggers and enhancers of tau fibrillization. Microsc. Res. Tech. 67 (2005) 141-155
5. Chirita C.N., Congdon E.E., Yin H., and Kuret J. Triggers of full-length tau aggregation: a role for partially folded intermediates. Biochemistry 44 (2005) 5862-5872
6. Chirita C.N., and Kuret J. Evidence for an intermediate in tau filament formation. Biochemistry 43 (2004) 1704-1714
7. Chirita C.N., Necula M., and Kuret J. Anionic micelles and vesicles induce tau fibrillization in vitro. J. Biol. Chem. 278 (2003) 25644-25650
8. Chirita C.N., Necula M., and Kuret J. Ligand-dependent inhibition and reversal of tau filament formation. Biochemistry 43 (2004) 2879-2887
9. Necula M., Chirita C.N., and Kuret J. Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: implications for the treatment of tauopathic neurodegenerative diseases. Biochemistry 44 (2005) 10227-10237
10. Congdon E.E., Necula M., Blackstone R.D., and Kuret J. Potency of a tau fibrillization inhibitor is influenced by its aggregation state. Arch. Biochem. Biophys. 465 (2007) 127-135
11. Mishra A., Behera R.K., Behera P.K., Mishra B.K., and Behera G.B. Cyanines during the 1990s: a review. Chem. Rev. 100 (2000) 1973-2011
12. May B.C., Fafarman A.T., Hong S.B., Rogers M., Deady L.W., Prusiner S.B., and Cohen F.E. Potent inhibition of scrapie prion replication in cultured cells by bis-acridines. Proc. Natl. Acad. Sci. USA 100 (2003) 3416-3421
13. Handl H.L., Vagner J., Han H., Mash E., Hruby V.J., and Gillies R.J. Hitting multiple targets with multimeric ligands. Expert Opin. Ther. Targets 8 (2004) 565-586
14. Herz A.H. Dye-dye interactions of cyanines in solution and at silver bromide surfaces. Photogr. Sci. Eng. 18 (1974) 323-335
15. Goedert M., Spillantini M.G., Jakes R., Rutherford D., and Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3 (1989) 519-526
16. Carmel G., Mager E.M., Binder L.I., and Kuret J. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271 (1996) 32789-32795
17. C.D. Wilson, Polymeric cyanine dyestuffs, U.S. Patent 2,425,772 (1947).
18. C.D. Wilson, Photographic emulsions, U.S. Patent 2,393,351 (1946).
19. D.W. Heseltine, D.A. Brooks, Mordants for bleachable filter layers, U.S. Patent 3,438,779 (1969).
20. Patnaik L.N., Pattanaik B.N., Mohanty M., and Satapathy A. Thin-layer chromatographic behavior of some styryl cyanine dyes derived from pyridine. J. Chromatogr. 481 (1989) 331-342
21. Necula M., and Kuret J. Electron microscopy as a quantitative assay for studying tau fibrillization. Anal. Biochem. 329 (2004) 238-246
22. West W., Lovell S.P., and Cooper W. Electronic spectra of cyanine dyes at low temperature. I. Monomeric and aggregate absorption spectra. Photogr. Sci. Eng. 14 (1970) 52-62
23. Chibisov A.K., Prokhorenko V.I., and Gorner H. Effects of surfactants on the aggregation behaviour of thiacarbocyanine dyes. Chem. Phys. 250 (1999) 47-60
24. Necula M., and Kuret J. A static laser light scattering assay for surfactant-induced tau fibrillization. Anal. Biochem. 333 (2004) 205-215
25. Masuda M., Suzuki N., Taniguchi S., Oikawa T., Nonaka T., Iwatsubo T., Hisanaga S., Goedert M., and Hasegawa M. Small-molecule inhibitors of α-synuclein filament assembly. Biochemistry 45 (2006) 6085-6094
26. Necula M., Kayed R., Milton S., and Glabe C.G. Small-molecule inhibitors of aggregation indicate that amyloid β oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 282 (2007) 10311-10324
27. Herz A.H. Aggregation of sensitizing dyes in solution and their adsorption on to silver halides. Adv. Colloid Interface Sci. 8 (1977) 237-298